Last update 11 Dec 2024

Secukinumab Biosimilar(CSPC Jushi Biomedicine)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
SYS 6012, SYS-6012, SYS6012
Target
IL-17A
Mechanism
IL-17A inhibitors(Interleukin 17A inhibitors)
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal Diseases
Active Indication
Plaque psoriasis
Inactive Indication-
Originator Organization
CSPC Megalith Biopharmaceutial Co., Ltd.
Active Organization
CSPC Megalith Biopharmaceutial Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Secukinumab Biosimilar(CSPC Jushi Biomedicine)
CTR20241390 / RecruitingPhase 3
评估SYS6012注射液与司库奇尤单抗注射液（可善挺®）治疗中度至重度斑块状银屑病的多中心、随机、双盲、平行、阳性对照等效性III期临床试验
[Translation] A multicenter, randomized, double-blind, parallel, positive-controlled Phase III clinical trial to evaluate the equivalence of SYS6012 injection and secukinumab injection (Cosentyx®) in the treatment of moderate to severe plaque psoriasis
CTR20233862 / CompletedPhase 1
比较健康男性受试者单次皮下注射SYS6012注射液和原研药后的随机、双盲、平行对照的药代动力学、安全性和免疫原性的I期研究
[Translation] A randomized, double-blind, parallel-controlled phase I study comparing the pharmacokinetics, safety, and immunogenicity of SYS6012 injection and the original drug after a single subcutaneous injection in healthy male subjects
100 Clinical Results associated with Secukinumab Biosimilar(CSPC Jushi Biomedicine)
Login to view more data
100 Translational Medicine associated with Secukinumab Biosimilar(CSPC Jushi Biomedicine)
Login to view more data
100 Patents (Medical) associated with Secukinumab Biosimilar(CSPC Jushi Biomedicine)
Login to view more data
100 Deals associated with Secukinumab Biosimilar(CSPC Jushi Biomedicine)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Plaque psoriasisPhase 3
CN
CSPC Megalith Biopharmaceutial Co., Ltd.
20 Jun 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free